REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 505 filers reported holding REPLIGEN CORP in Q4 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,087,974 | +43.7% | 19,420 | +27.8% | 0.00% | +100.0% |
| Q2 2023 | $2,149,060 | -33.7% | 15,192 | -21.1% | 0.00% | -50.0% |
| Q1 2023 | $3,239,920 | -50.1% | 19,244 | -49.8% | 0.00% | -42.9% |
| Q4 2022 | $6,495,070 | -70.1% | 38,362 | -67.0% | 0.01% | -72.0% |
| Q3 2022 | $21,729,000 | +346.2% | 116,133 | +287.3% | 0.02% | +316.7% |
| Q2 2022 | $4,870,000 | -2.2% | 29,985 | -5.3% | 0.01% | +20.0% |
| Q1 2022 | $4,979,000 | -43.1% | 31,666 | -4.2% | 0.01% | -37.5% |
| Q4 2021 | $8,752,000 | -12.2% | 33,046 | -4.2% | 0.01% | -20.0% |
| Q3 2021 | $9,965,000 | +102.3% | 34,481 | +39.8% | 0.01% | +100.0% |
| Q2 2021 | $4,925,000 | -0.8% | 24,673 | -3.4% | 0.01% | 0.0% |
| Q1 2021 | $4,966,000 | -20.6% | 25,546 | -21.7% | 0.01% | -28.6% |
| Q4 2020 | $6,253,000 | +13.6% | 32,631 | -12.5% | 0.01% | 0.0% |
| Q3 2020 | $5,504,000 | +77.8% | 37,302 | +49.0% | 0.01% | +75.0% |
| Q2 2020 | $3,095,000 | -38.8% | 25,035 | -52.2% | 0.00% | 0.0% |
| Q1 2020 | $5,056,000 | +40.6% | 52,364 | +34.6% | 0.00% | 0.0% |
| Q4 2019 | $3,597,000 | +29.8% | 38,889 | +7.6% | 0.00% | 0.0% |
| Q3 2019 | $2,771,000 | +1922.6% | 36,137 | +2160.0% | 0.00% | – |
| Q2 2019 | $137,000 | -47.1% | 1,599 | -63.5% | 0.00% | -100.0% |
| Q1 2019 | $259,000 | -54.8% | 4,381 | -59.7% | 0.00% | 0.0% |
| Q4 2018 | $573,000 | -1.2% | 10,873 | +4.0% | 0.00% | 0.0% |
| Q3 2018 | $580,000 | +84.7% | 10,451 | +56.7% | 0.00% | 0.0% |
| Q2 2018 | $314,000 | +51.0% | 6,670 | +15.9% | 0.00% | – |
| Q1 2018 | $208,000 | +38.7% | 5,755 | +38.9% | 0.00% | – |
| Q4 2017 | $150,000 | +3.4% | 4,143 | +9.5% | 0.00% | – |
| Q3 2017 | $145,000 | -12.7% | 3,785 | -5.4% | 0.00% | – |
| Q2 2017 | $166,000 | +38.3% | 4,001 | +17.7% | 0.00% | – |
| Q1 2017 | $120,000 | +103.4% | 3,400 | +76.6% | 0.00% | – |
| Q4 2016 | $59,000 | -1.7% | 1,925 | -2.4% | 0.00% | – |
| Q3 2016 | $60,000 | +36.4% | 1,972 | +22.1% | 0.00% | – |
| Q2 2016 | $44,000 | +83.3% | 1,615 | +77.5% | 0.00% | – |
| Q1 2016 | $24,000 | -65.7% | 910 | -46.1% | 0.00% | – |
| Q2 2015 | $70,000 | – | 1,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |